Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsAMEXFinancialsFinancial - MortgagesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for IOR yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Improve free cash flow yield from negative levels | A primary condition in INCOME OPPORTUNITY REALTY INVESTORS INC's published investment case. The stated target is free cash flow yield >= 0% next 4 quarters. | Broken | free cash flow yield remains below 0% next 4 quarters | Free cash flow yield: -0.45% As of 2026-11-04; trailing twelve months. The target timing and basis require a separate assessment. Nov 4, 2026-0.45 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
IOR is a financially sensitive business with a fragile earnings profile and elevated risk. Its current long-term thesis is on watch: recent performance is weak and below its industry cohort, though the signal has shifted from mixed to mildly favorable.
The evidence describes IOR as expensive versus peers, with a 0.56 premium, but says fragility is low because weakness in execution quality is not joined by the full expensive, weak, and turbulent combination. The market’s expectations are therefore not described as pricing in every source of risk, while the valuation still leaves limited room for weak results to improve the setup.
Near term, earnings may remain uneven: second-quarter net income and diluted earnings per share declined from the first quarter as interest income from related parties fell. Operating expenses stayed steady at about $97,000 per quarter, but reliance on related-party interest income remains a key weakness.
Over the next year to three years, the thesis hinges on whether management can stabilize earnings and interest income while keeping expenses controlled. Sector conditions also matter: rate cuts could weigh on Financials, while continued earnings strength at RKT, PFSI, and UWMC could support sector momentum; misses or lower guidance could weaken that support.
IOR’s multi-year view is cautious, with fragile earnings, elevated risk, and an expensive valuation set against steady expense control and a mildly favorable recent signal. The main test is whether earnings stabilize and sector support persists. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Maintain positive net income and profit margins |
| A primary condition in INCOME OPPORTUNITY REALTY INVESTORS INC's published investment case. The stated target is net income remains positive over next 4 quarters. |
| Intact |
| net income turns negative in any quarter |
Net income: $705,000 FY2026-Q2; GAAP. Published target: net income remains positive over next 4 quarters. Target period is not explicitly aligned with this observation. Aug 6, 2026705,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain valuation premium justified by fundamentals | Its price-to-earnings ratio is 18.8, higher than peers at 12.8, showing some premium. | Intact | P/E falls below peer median 12.8 | P/E (TTM): 20.39x As of 2026-11-04; trailing twelve months. The target timing and basis require a separate assessment. Nov 4, 202620.3875 ratio · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.